Mini Review
Volume 17 Issue 7 - 2021
Tenofovir as a Treatment for COVID-19
Usama Alanan*, Ahmed A Alhusein and Mariana Haydar
Faculty of Pharmacy, Manara University, Syria
*Corresponding Author: Usama Alanan, Faculty of Pharmacy, Manara University, Syria.
Received: March 21, 2021; Published: June 30, 2021


After the emergence of SARS-CoV-2 - the cause of COVID-19 - we need an effective antiviral agent to stop the spread of this epidemic. Tenofovir (of the same pharmacological group as Remdesivir) speeds up recovery in COVID-19 patients by inhibiting viral RNA polyphens. Tenofovir could be an option for treating COVID-19 patients due to its good availability in the pharmaceutical market and many studies on its therapeutic properties and effects over a long period of time (such as treatment of HIV and hepatitis B virus) and its acceptable price in many countries (especially Third World countries) compared to other proposed drugs for treating Covid 19.

Keywords: Tenofovir; COVID-19


  1. J Chen., et al. “Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19)”. Journal of Medical Virology 12 (2019): 2019-2021.
  2. Ju Jingyue., et al. “Nucleotide analogues as inhibitors of SARS-CoV polymerase”. Bio Rxiv (2020).
  3. M Chien., et al. “Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19”. Journal of Proteome Research (2020).
  4. JL Blanco., et al. “COVID-19 in patients with HIV: clinical case series”. Lancet HIV5 (2020): e314-e316.
  5. Sayad Babak., et al. “Sofosbuvir as repurposed antiviral drug against COVID-19: why were we convinced to evaluate the drug in a registered/approved clinical trial?”. Archives of Medical Research (2020).‏
  6. Lai Chih-Cheng., et al. “Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges”. International Journal of Antimicrobial Agents (2020): 105924.‏
  7. Sanders James M., et al. “Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review”. The Journal of the American Medical Association18 (2020): 1824-1836.
  8. Calcagno Andrea., et al. “Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines”. The Pharmacogenomics Journal6 (2016): 514-518.
  9. Gao Yan., et al. “Structure of the RNA-dependent RNA polymerase from COVID-19 virus”. Science6492 (2020): 779-782.
  10. Jockusch Steffen., et al. “A Library of Nucleotide Analogues Terminate RNA Synthesis Catalyzed by Polymerases of Coronaviruses Causing SARS and COVID-19”. Bio Rxiv (2020).‏
  11. C Palarach., et al. “Ac c ep te d us cr ip,” 0813 (2017): 1-30.
  12. AA Elfiky. “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study”. Life Sciences 253 (2020).
  13. BP Kearney., et al. “Tenofovir disoproxil fumarate: Clinical pharmacology and pharmacokinetics”. Clinical Pharmacokinetics9 (2004): 595-612.
  14. Lyseng-Williamson., et al. “Tenofovir disoproxil fumarate”. Drugs3 (2005): 413-432.‏
  15. G Clososki., et al. “Tenofovir Disoproxil Fumarate: New Chemical Developments and Encouraging in vitro Biological Results for SARS-CoV-2”. Journal of the Brazilian Chemical Society8 (2020): 1552-1556.
  16. McHugh Kevin J. "Employing drug delivery strategies to create safe and effective pharmaceuticals for COVID‐19”. Bioengineering and Translational Medicine (2020).
  17. N Ford., et al. “Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment”. Journal of the International AIDS Society4 (2020): 1-9.
  18. G Härter., et al. “COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients”. Infection (2020): 0123456789.
  19. JP Ridgway., et al. “A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois”. AIDS Patient Care STDS8 (2020): 331-335.
  20. Chhikara Bhupender S., et al. “Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics”. Chemical Biology Letters1 (2020): 63-72.‏
  21. Mongia Aanchal., et al. “A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials”. Ar Xiv Preprint (2020).‏
Citation: Usama Alanan., et al. “Tenofovir as a Treatment for COVID-19”. EC Microbiology 17.7 (2021): 100-103.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

August Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the August issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before August 18, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.